Sexual health after orthotopic liver transplantation

Jin K. Ho, Hin Hin Ko, David F. Schaeffer, Siegfried R. Erb, Cherise Wong, Andrzej K. Buczkowski, Charles H. Scudamore, Eric M. Yoshida – 26 September 2006 – Many studies have reported improved health‐related quality of life outcomes after orthotopic liver transplantation; however, specific research regarding sexual health in liver transplant recipients is limited. We surveyed liver transplant recipients to determine the prevalence of sexual dysfunction. Of the 320 adult liver transplant recipients surveyed by mailed questionnaire, 150 responded (42%). The median age was 54 years.

Documented deaths of hepatic lobe donors for living donor liver transplantation

James F. Trotter, Rene Adam, Chung Mau Lo, Jeremy Kenison – 26 September 2006 – The actual risk of death in hepatic lobe donors for living donor liver transplantation (LDLT) is unknown because of the lack of a comprehensive database. In the absence of a definitive estimate of the risk of donor death, the medical literature has become replete with anecdotal reports of donor deaths, many of which cannot be substantiated.

An analysis of the UNOS liver transplant registry: High serum alpha‐fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma

Nyingi Kemmer, Guy Neff, Tiffany Kaiser, Victoria Zacharias, Mark Thomas, Amit Tevar, Supriya Satwah, Rakesh Shukla, Joseph Buell – 26 September 2006 – The current United Network for Organ Sharing (UNOS) criteria for liver transplantation gives priority to patients with elevated serum alpha‐fetoprotein (AFP; ≥ 500 ng/mL) in the absence of radiologic evidence of a hepatic mass. Reports have shown that an elevated serum AFP is a poor diagnostic indicator for hepatocellular carcinoma (HCC) in patients with cirrhosis.

Subscribe to